Us Bancorp \De\ Fibrogen Inc Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Fibrogen Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 29 shares of FGEN stock, worth $22. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 8,444 99.66%

Holding current value

$22

Previous $3,000 100.0%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$0.3 - $0.58 $2,524 - $4,880	-8,415 Reduced 99.66%	29 $0
Q3 2024 Oct 28, 2024	SELL	$0.33 - $1.26 $528 - $2,016	-1,600 Reduced 15.93%	8,444 $3,000
Q1 2024 May 07, 2024	SELL	$0.73 - $2.73 $651 - $2,435	-892 Reduced 8.16%	10,044 $23,000
Q4 2023 Feb 09, 2024	BUY	$0.38 - $0.91 $3,936 - $9,425	10,358 Added 1792.04%	10,936 $9,000
Q3 2023 Nov 03, 2023	SELL	$0.79 - $2.83 $60 - $215	-76 Reduced 11.62%	578 $0
Q2 2023 Aug 09, 2023	SELL	$2.49 - $20.59 $164 - $1,358	-66 Reduced 9.17%	654 $1,000
Q4 2022 Feb 13, 2023	SELL	$13.27 - $17.73 $5,122 - $6,843	-386 Reduced 34.9%	720 $11,000
Q3 2022 Oct 27, 2022	SELL	$11.4 - $14.6 $296 - $379	-26 Reduced 2.3%	1,106 $14,000
Q2 2022 Aug 01, 2022	SELL	$7.94 - $12.96 $1,492 - $2,436	-188 Reduced 14.24%	1,132 $12,000
Q1 2022 May 11, 2022	SELL	$12.02 - $16.79 $17,549 - $24,513	-1,460 Reduced 52.52%	1,320 $16,000
Q4 2021 Feb 11, 2022	SELL	$9.93 - $15.39 $2,264 - $3,508	-228 Reduced 7.58%	2,780 $40,000
Q3 2021 Nov 10, 2021	SELL	$10.18 - $26.64 $1,394 - $3,649	-137 Reduced 4.36%	3,008 $31,000
Q2 2021 Aug 05, 2021	SELL	$18.57 - $35.68 $193,833 - $372,427	-10,438 Reduced 76.85%	3,145 $84,000
Q1 2021 Apr 28, 2021	BUY	$31.0 - $55.72 $50,623 - $90,990	1,633 Added 13.67%	13,583 $472,000
Q4 2020 Feb 04, 2021	SELL	$37.09 - $48.97 $63,794 - $84,228	-1,720 Reduced 12.58%	11,950 $443,000
Q3 2020 Nov 10, 2020	BUY	$40.47 - $45.5 $349,094 - $392,483	8,626 Added 171.02%	13,670 $562,000
Q2 2020 Aug 07, 2020	BUY	$32.57 - $42.83 $15,894 - $20,901	488 Added 10.71%	5,044 $205,000
Q1 2020 May 13, 2020	BUY	$23.3 - $45.96 $105,828 - $208,750	4,542 Added 32442.86%	4,556 $158,000
Q4 2019 Feb 04, 2020	SELL	$34.58 - $48.06 $75,107 - $104,386	-2,172 Reduced 99.36%	14 $1,000
Q3 2019 Nov 08, 2019	BUY	$36.98 - $48.45 $517 - $678	14 Added 0.64%	2,186 $81,000
Q2 2019 Aug 13, 2019	BUY	$35.13 - $55.53 $33,830 - $53,475	963 Added 79.65%	2,172 $98,000
Q1 2019 May 08, 2019	BUY	$42.83 - $59.91 $40,859 - $57,154	954 Added 374.12%	1,209 $65,000
Q4 2018 Feb 13, 2019	SELL	$37.97 - $60.16 $8,125 - $12,874	-214 Reduced 45.63%	255 $12,000
Q3 2018 Nov 01, 2018	BUY	$56.3 - $67.25 $731 - $874	13 Added 2.85%	469 $29,000
Q2 2018 Aug 08, 2018	SELL	$44.9 - $64.95 $12,212 - $17,666	-272 Reduced 37.36%	456 $28,000
Q1 2018 May 08, 2018	BUY	$45.35 - $61.65 $4,897 - $6,658	108 Added 17.42%	728 $34,000
Q4 2017 Feb 02, 2018	BUY	$41.95 - $60.1 $8,138 - $11,659	194 Added 45.54%	620 $30,000
Q3 2017 Nov 13, 2017	BUY	$33.4 - $53.9 $14,228 - $22,961	426	426 $23,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

37.4M

Call Options Held

351K

Put Options Held

105K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $72.2M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account